Results 81 to 90 of about 32,635 (169)

Combination of Rhamnetin and RXP03 Mitigates Venom-Induced Toxicity in Murine Models: Preclinical Insights into Dual-Target Antivenom Therapy

open access: yesToxins
Snakebite is a significant global public health challenge, and the limited application of antivenom has driven the exploration of novel therapies. Combination therapy using small-molecule drugs targeting phospholipases A2 (PLA2) and metalloproteinases ...
Jianqi Zhao   +3 more
doaj   +1 more source

Isolation, characterization, and expression of the Montivipera raddei (Caucasus viper) venom metalloprotease-like protein

open access: yesResearch in Pharmaceutical Sciences
Background and purpose: Snake venom contains numerous proteolytic enzymes, including metalloproteases. This study aimed to isolate, characterize the metalloproteinase from Montivipera raddei venom and insert its cDNA into a host cell genome for ...
Zohreh Jafari   +4 more
doaj   +1 more source

Complement System Inhibition Modulates the Pro-Inflammatory Effects of a Snake Venom Metalloproteinase. [PDF]

open access: yesFront Immunol, 2019
Luchini LSG   +3 more
europepmc   +1 more source

Natural inhibitors of snake venom metalloproteinases

open access: yesNatural inhibitors of snake venom metalloproteinases
Snakebites are a hazard in the tropical world. Although antivenom therapy is effective, it is beset with inherent drawbacks. A better understanding of the major components of snake venoms and their neutralisation will help in improving snakebite treatment.
openaire  

Home - About - Disclaimer - Privacy